Kallikrein 10 Antikörper (AA 65-165)
Kurzübersicht für Kallikrein 10 Antikörper (AA 65-165) (ABIN741630)
Target
Alle Kallikrein 10 (KLK10) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 65-165
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Cow
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NES1/KLK10
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
Urinary kallikrein 10 predicts the incurability of gastric cancer." in: Oncotarget, Vol. 8, Issue 17, pp. 29247-29257, (2018) (PubMed).
: "Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro." in: Oncology reports, Vol. 34, Issue 5, pp. 2325-32, (2015) (PubMed).
: "Chemoprevention Activity of Dipyridamole in the MMTV-PyMT Transgenic Mouse Model of Breast Cancer." in: Cancer prevention research (Philadelphia, Pa.), Vol. 6, Issue 5, pp. 437-47, (2013) (PubMed).
: "
-
Urinary kallikrein 10 predicts the incurability of gastric cancer." in: Oncotarget, Vol. 8, Issue 17, pp. 29247-29257, (2018) (PubMed).
-
- Kallikrein 10 (KLK10)
-
Andere Bezeichnung
- NES1/KLK10
-
Hintergrund
-
Synonyms: NES1, PRSSL1, Kallikrein-10, Normal epithelial cell-specific 1, Protease serine-like 1, KLK10
Background: Has a tumor-suppressor role for NES1 in breast and prostate cancer.
-
Gen-ID
- 5655
-
UniProt
- O43240
-
Pathways
- Komplementsystem
Target
-